A multicenter, prospective, randomized, placebo controlled, adaptive design study performed to evaluate the safety and the efficacy of XXX (Cream) in debridement of Venous Leg Ulcers.
Ages between 18 and 90 years.
Patients with VLU
Wound present for at least 4 weeks and maximum 52 weeks
Area of the wound between 5-100 square centimeters.